Preimplantation genetic testing is an integral part of assisted reproductive technologies (ART) contributing to an early form of prenatal diagnosis to identify abnormal and normal embryos (before transfer)
(Preimplantation Genetic Testing- Aneuploidy)
It screens for all the 23 pairs of chromosomes in the embryo and checks for additional, abnormal or missing chromosomes (Aneuploidy). PGT-A enables to choose and transplant embryos with standard chromosome number (Euploid embryos), thus reducing risk for chromosomal disorders in a pregnancy.

SETGENE PGT-A employs cutting-edge Next-Generation Sequencing (NGS) technology.
(Preimplantation genetic testing for monogenic disorders)
Preimplantation genetic testing for monogenic disorders means testing the embryos for single gene disorders or inherited disorders. PGT-M is recommended to couples who are carriers and are at increased risk of inheriting a specific genetic disorder to their offspring.

(Preimplantation genetic testing for structural rearrangements)
Detects chromosomal rearrangements, such as unbalanced translocations, which put embryos at risk of abnormal chromosome numbers or structures.
When either of the partners is carrier of a chromosomal structural rearrangement, such as:
